
Intuitive Surgical (ISRG) Stock Forecast & Price Target
Intuitive Surgical (ISRG) Analyst Ratings
Bulls say
Intuitive Surgical demonstrates robust growth in procedure volumes, particularly in the US, with a notable 90 basis point increase in year-over-year procedure growth, largely attributed to advancements in General Surgery. The installation of both Ion and SP systems reflects strong demand, with Ion utilization growing by 11% and SP utilization increasing by 21%, indicative of the company's expanding market presence and customer adoption. The upward trend in average selling prices (ASPs) for systems further underscores Intuitive Surgical's financial strength and positions the company favorably in a recovering surgical market.
Bears say
The analysis indicates that Intuitive Surgical is facing pressures on average selling prices (ASPs) for both systems and instrumentation and accessories (I&A), primarily driven by a decline in bariatric procedures and shifts in procedural trends. Despite the launch of the da Vinci System 5 (Dv5), which accounts for all system sales growth, the contribution of the Dv5 to I&A revenue growth appears limited, suggesting underlying issues in procedural growth that impact the entire business model. Additionally, the slower-than-expected growth in the Japanese market, alongside risks from increased competition and challenges in the capital purchasing environment, further compounds concerns regarding the company's future performance.
This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.
Intuitive Surgical (ISRG) Analyst Forecast & Price Prediction
Start investing in Intuitive Surgical (ISRG)
Order type
Buy in
Order amount
Est. shares
0 shares